This settlement with seven state attorneys general represents another critical part in our ongoing commitment to resolve issues from the company’s past. The terms of the agreement, like prior settlements, provide financial resources to further combat underage use and develop cessation programs and reflect our current business practices, which were implemented as part of our company-wide reset in the fall of 2019. Since then, underage use of JUUL products has declined by 95% based on the National Youth Tobacco Survey.
With this settlement, we are nearing total resolution of the company’s historical legal challenges and securing certainty for our future. We have now settled with 47 states and territories, providing over $1 billion to participating states. This is in addition to our global resolution of the U.S. private litigation that covers more than 5,000 cases brought by approximately 10,000 plaintiffs.
Now we are positioned to dedicate even greater focus on our path forward to maximize the value and impact of our product technology and scientific foundation. Our technology already has transitioned over two million adult smokers from combustible cigarettes. And our priorities remain to secure authorization of our PMTAs based on the science and lead the category with innovation to accelerate our mission and advance tobacco harm reduction for over 31 million adult smokers in the U.S. and over 1 billion adult smokers worldwide.
August 8, 2025
Juul Labs filed complaints today against NJOY and Altria with the United States International Trade Commission (ITC) and the United States District Court for…
July 17, 2025
Today the U.S. Food and Drug Administration (FDA) issued marketing granted orders (MGOs) for the JUUL System. As part of our 2020 applications, we…
April 30, 2025